From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Now that we have a clear view of price contracts, sales, chargebacks, rebates and inventory analytic deliverables, we have a 50% reduction in our overall cross-functional efforts related to GTN accrual management and forecasting. ”
ICyte integrates the four net revenue workflows, including Channel, Patient, Contracts & Pricing, and Gross-to-Net (GTN) in one pharma market access data and application suite. These four workflows are tightly linked; the inputs to one are the outputs from another. With this data and application integration, our market access software enables IntegriChain to uniquely connect the commercial, financial, and operational dimensions of drug access and profitability. Discover more by clicking each section below.
With ICyte, pharmaceutical and biotech organizations improve market access by quickly transforming patient, payer, complex transaction, and channel data into actionable insights. Contract & Pricing teams can manage regulatory processes, risks, delays, compliance issues and revenue leakage.
Commercial and market access leaders can align on optimal channel design, using syndicated data to capture how the product is distributed to points of care. Our pharma market access software provides:
Optimizing the net revenue-patient access equation is top-of-mind to all financial executives, regardless of the size or complexity of their company.
The key to achieving an accurate, transparent, and audit-ready gross-to-net (GTN) forecast is to have reliable, trusted inputs that cover all facets of commercialization including:
For most pharmaceutical organizations, this data exists in different systems, in different formats, and with different degrees of access. The ICyte Platform changes all of this. By building a commercialization strategy on market access software, all of the required GTN inputs are stored, mastered, and curated in a common manner on the same platform.
Discover the path to more accurate, automated GTN processes with ICyte’s:
Discover how ICyte’s integrated data and analytics capabilities can deliver superior financial insights including:
Pharmaceutical companies that use ICyte for their market access needs see a wealth of operational benefits including:
Best practice data visualizations and analytics dashboards for hundreds of use cases across operational support, forecasting, national account management, order to cash, and field sales
User-friendly report and dashboard builder seats for customer power users
Framework for rapid development and ongoing management of data interfaces with customer data warehouses and CRM platforms.
Standard extract framework enables both Productized and Custom extracts to be developed, scheduled, and deployed quickly.
Modular tokenization approach enables the integration of patient-level data with third-party data providers.
Monitoring of incoming data and alerting for data timeliness issues. Profiling of incoming data feeds to ensure completeness and accuracy.
Easily configurable data quality checks to align with Data Provider File Interface and Contractual Agreements.
A team of Data Quality Analysts monitor for Data Quality issues; investigating the issue, performing outreach to the data provider, and ensuring a timely resolution.
Reusable data interfaces with over 500 PBMs, states, 3PLs, distributors, pharmacies, and patient service providers
Ability to ingest and map a variety of input formats and data types.
HIPAA Compliant and highly secure environment for ingestion and storage of protected health information (PHI) and personal identifiable information (PII)
Integration of all transaction data to a proprietary reference database of US healthcare organizations, sites of care, business structures, and classes of trade
Best in-class probabilistic Patient Matching to meet the needs of your network. Able to handle both Identifiable and Tokenized Patient Data.
Master Data Stewards review individual cases of potential False Negatives and False Positives and remediate these discrepancies in the system on a daily basis.
Contact Our Market Access Consultants
This case study highlights how IntegriChain delivered their innovative ICyte Saas Platform to help the manufacturer identify and resolve obstacles.
Read the Case Study
Co-Founder and Chief Executive Officer Josh Halpern reviews key industry trends impacting product commercialization and access, including the shift to true data-driven commercialization.
Read the post
